What is cytokeratins? | IDL Biotech
IDL Biotech

CLOSE MENU

June 2018

What is cytokeratins?

Cancer affects everyone – the young and old, the rich and poor, men, women and children – and represents a tremendous burden on patients, families and societies. Cancer is one of the leading causes of death in the world.

Normal cells are constantly dividing, but in cancer, abnormal cell growth occurs. This causes the protein cytokeratin to leak out which can be measured with efficient diagnostic tools. Thanks to modern technology, IDL can quickly diagnose several kinds of cancer in a non-invasive and pain free manner.

 

All IDL tumor marker assays are designed to measure tumor cell activity through the detection of soluble fragments of cytokeratins, the intermediate filament proteins that contribute to the mechanical integrity of the epithelial cells. The benefit of determining cytokeratin levels in the body lies both in early detection of cancer recurrence, and in the early assessment of therapy response.

IDL Biotech signs distributor agreement in Ghana

IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with Res Health Consult Ltd covering Ghana. The agreement covers the sale of TUBEX® TF.

IDL Biotech includes additional clinics in its ongoing multicenter study for UBC® Rapid in Sweden.

IDL Biotech currently has a number of ongoing clinical studies both internationally and in Sweden, with the aim of demonstrating the clinical benefit of UBC® Rapid in bladder cancer and having the test included as a complement in the follow-up of patients with bladder cancer who are classified as high risk.

IDL Biotech

Skip this intro